
ABeta Amyloidosis, Italian Type: Genetic Testing
Amyloid fibrils build up in tissues and organs when amyloid precursor proteins are processed abnormally; DNA analysis names the mutations involved.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Amyloid fibrils build up in tissues and organs when amyloid precursor proteins are processed abnormally; DNA analysis names the mutations involved.

Amyloid from an APP gene mutation deposits mainly in the heart, thickening and stiffening the muscle, which sets it apart from other cardiac amyloidosis.

A rare cone cell disorder of the retina, achromatopsia causes loss of color vision, reduced acuity and light sensitivity, and is mostly autosomal recessive.

Recurrent respiratory infections and autoimmunity can signal APDS, an immune disorder in which PIK3CD or PIK3R1 mutations leave the PI3K/mTOR pathway overactive.

Anemia, bleeding and frequent infections follow megakaryoblast overgrowth in AMKL without Down syndrome; GATA1, MPL and JAK2 findings shape prognosis.

Explore how genetic testing identifies mutations in Adrenoleukodystrophy, offering early diagnosis, personalized care, and family planning guidance for this rare disorder.

Explore how genetic testing revolutionizes Hirschsprung's Disease diagnosis and management by identifying mutations, predicting severity, and personalizing treatment.

Immune activation that mimics a viral infection causes developmental delay, spasticity and skin lesions, traced to TREX1, RNASEH2A-C, ADAR, SAMHD1 or IFIH1 mutations.